Market›Health Care›Pharmaceuticals›Pharmaceuticals
CONTINEUM THERAPEUTI A

CTNM

$12.41Apr 05, 2024 – Apr 24, 2026
Health CarePharmaceuticals$478M
MVM
+$3.2M
TD Variance
5.882

Every news event mapped to its market reaction — 57 events, 25 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-11-21-17.7%earningsSeeking AlphaContineum falls after missing main goals in multiple sclerosis trial
2024-08-14+12.2%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$0.39
2025-03-06+12.2%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$0.56
2025-08-06+11.5%earningsSeeking AlphaContineum Therapeutics Non-GAAP EPS of -$0.62
2025-11-20-11.4%newsInvesting.comContineum stock falls after multiple sclerosis drug fails in trial - Investing.com
2025-11-20-11.4%newsBusiness WireContineum Therapeutics Reports Topline Data From Its Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) - Business Wire
2026-01-27+11.1%earningsSimply Wall St.Contineum Therapeutics, Inc. (NASDAQ:CTNM) surges 10%; retail investors who own 51% shares profited along with institutions
2025-12-12-10.2%newsSeeking AlphaContineum Therapeutics stock drops as company prices upsized $90 million offering
2025-05-15-9.7%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$0.62
2026-02-18+8.7%newsBusiness WireContineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
2024-11-06+8.5%newsBusiness WireContineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
2025-09-30-7.6%newsYahoo FinanceHere's Why We're Not Too Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn Situation - Yahoo Finance
2026-03-02-7.3%earningsZacksBeat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus
2026-03-02-7.3%newsInvesting.comContineum Therapeutics (CTNM) CMO sells $54,220 in stock - Investing.com
2025-12-11-6.3%newsSeeking AlphaContineum Therapeutics announces proposed $75M public offering
2025-12-11-6.3%newsStock TitanContineum Therapeutics (NASDAQ: CTNM) sets price for upsized $90.0M offering - Stock Titan
2025-12-11-6.3%newsStock TitanContineum Therapeutics (Nasdaq: CTNM) starts proposed $75.0M underwritten stock sale - Stock Titan
2026-04-06-5.8%newsInvesting.comContineum Therapeutics CSO sells $56k in CTNM stock - Investing.com
2026-04-06-5.8%executiveStock TitanPre-planned stock sale by Contineum (CTNM) chief scientific officer - Stock Titan
2026-04-06-5.8%newsStock TitanDaniel Lorrain sells via 10b5-1; CTNM (NASDAQ: CTNM) Form 144 notice - Stock Titan
2026-04-06-5.8%newsCổng thông tin điện tử Tỉnh Sơn LaShould I Hold Contineum (CTNM) Stock Now | Price at $13.38, Down 0.48% - Top Trending Breakouts - Cổng thông tin điện tử Tỉnh Sơn La
2024-11-07+5.5%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$0.40
2026-03-05-4.7%newsBusiness WireContineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
2026-03-05-4.7%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$0.49
2026-03-05-4.7%newsBusiness WireContineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
2025-07-08+4.7%newsMoomooContineum Therapeutics (CTNM) Stock Forum and Discussion - Moomoo
2026-04-23-4.6%earningsCổng thông tin điện tử tỉnh Lào CaiIs Contineum (CTNM) stock holding key zones | Q4 2025: EPS Misses Views - Fast Rising Picks - Cổng thông tin điện tử tỉnh Lào Cai
2024-06-13-4.2%newsSeeking AlphaContineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model
2024-07-03-4.2%earningsMarketBeatContineum Therapeutics (CTNM) Institutional Ownership 2026 - MarketBeat
2026-03-13-4.0%newsBusiness WireContineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2025-05-08-3.6%newsIntellectia AICTNM Forecast — Price Prediction for 2026. Should I Buy CTNM? - Intellectia AI
2026-02-04-3.1%newsZacksIs Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year?
2026-02-04-3.1%newsYahoo FinanceIs Contineum Therapeutics, Inc. (CTNM) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
2026-03-03-2.9%newsBusiness WireContineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference
2026-03-03-2.9%newsStock TitanHear Contineum management at 2026 Leerink healthcare conference webcast - Stock Titan
2025-05-14+2.8%newsBusiness WireContineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
2024-06-02+2.6%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Contineum Therapeutics, Inc. (CTNM) - Zacks Investment Research
2024-10-22+2.1%newsSeeking AlphaContineum draws bullish view at Baird on de-risked assets
2026-03-15+1.8%newsMarketBeatContineum Therapeutics Highlights PIPE-791 IPF Trial, J&J-Backed PIPE-307 Catalysts at Leerink Conference
2025-10-30+1.8%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$0.45
2025-10-30+1.8%newsBusiness WireContineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
2024-04-30-1.5%newsSeeking AlphaStifel, Morgan Stanley bullish on newly public Contineum
2024-05-16+1.3%earningsSeeking AlphaContineum Therapeutics GAAP EPS of -$3.55
2024-04-06-1.0%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2024-04-06-1.0%earningsMarketBeatContineum Therapeutics (CTNM) Stock Price, News & Analysis - MarketBeat
2024-04-06-1.0%analystTradingViewCTNM Forecast — Price Target — Prediction for 2027 - TradingView
2025-04-28-0.7%executiveSeeking AlphaContineum Therapeutics appoints Timothy Watkins as Chief Medical Officer
2026-04-16+0.7%earningsMarketBeatContineum Therapeutics (NASDAQ:CTNM) Stock Price Up 2.2% - Here's What Happened - MarketBeat
2026-04-16+0.7%earningsMarketBeatContineum Therapeutics, Inc. (NASDAQ:CTNM) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
2026-04-17+0.3%newsStock TitanMillennium Group (CTNM) reports shared 1,658,349-share stake via Schedule 13G - Stock Titan
2024-09-30-0.2%newsSeeking AlphaIPO Roundup: FrontView REIT, StandardAero and more
2026-04-19-0.2%newsSimply Wall St.We Think Contineum Therapeutics (NASDAQ:CTNM) Can Afford To Drive Business Growth
2026-04-19-0.2%newsYahoo FinanceWe Think Contineum Therapeutics (NASDAQ:CTNM) Can Afford To Drive Business Growth - Yahoo Finance
2026-04-18-0.2%newsCổng thông tin điện tử Tỉnh Sơn LaContineum (CTNM) Stock: Risk Assessment (Investors Pile In) 2026-04-18 - Crowd Sentiment Stocks - Cổng thông tin điện tử Tỉnh Sơn La
2024-04-05—newsSeeking AlphaContineum Therapeutics stock slides 10% following $110M IPO
2024-04-05—newsSeeking AlphaContineum Therapeutics prices initial offering at $16 per share
2024-04-05—newsFierce BiotechContineum lowers expectations for $110M IPO as J&J-allied biotech goes public - Fierce Biotech
tickerdossier.comtickerdossier.substack.com